Your browser doesn't support javascript.
loading
MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants.
Lee, Sua; Jang, Shina; Kang, Jihoon; Park, Soo Bin; Han, Young Woo; Nam, Hyemi; Kim, Munkyung; Lee, Jeewon; Cho, Ki Joon; Kim, Jeonghun; Oh, Miyoung; Ryu, Jihye; Seok, Jong Hyeon; Kim, Yunhwa; Lee, Jee-Boong; Park, Man-Seong; Kim, Yong-Sung; Park, Hosun; Kim, Dong-Sik.
Afiliación
  • Lee S; Department of Protein Engineering, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Jang S; Department of Protein Engineering, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Kang J; Department of Protein Engineering, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Park SB; Department of Protein Engineering, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Han YW; Department of Infectious Disease Research, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Nam H; Department of Target ID & Assay Development, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Kim M; Department of Target ID & Assay Development, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Lee J; Department of Target ID & Assay Development, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Cho KJ; Department of Protein Engineering, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Kim J; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, South Korea.
  • Oh M; Department of Protein Engineering, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Ryu J; Department of Translational Research, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Seok JH; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, South Korea.
  • Kim Y; Department of Microbiology, College of Medicine, Yeungnam University, Daegu, South Korea.
  • Lee JB; Department of Target ID & Assay Development, Mogam Institute for Biomedical Research, Yongin, South Korea.
  • Park MS; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, South Korea.
  • Kim YS; Department of Molecular Science and Technology, Ajou University, Suwon, South Korea.
  • Park H; Department of Microbiology, College of Medicine, Yeungnam University, Daegu, South Korea.
  • Kim DS; Department of Protein Engineering, Mogam Institute for Biomedical Research, Yongin, South Korea.
Front Immunol ; 12: 778829, 2021.
Article en En | MEDLINE | ID: mdl-34868052
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Monoclonales / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Monoclonales / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Suiza